Welcome to CDC stacks | Graphene Oxide, But Not Fullerenes, Targets Immunoproteasomes and Suppresses Antigen Presentation by Dendritic Cells - 41955 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Graphene Oxide, But Not Fullerenes, Targets Immunoproteasomes and Suppresses Antigen Presentation by Dendritic Cells
Filetype[PDF-822.14 KB]


Details:
No Related Documents.
You May Also Like:
  1. Ins and Outs in Environmental Safety Studies of Asthma and Engineered Nanomaterials
    Personal Author:
    Dobrovolskaia, Marina A.; Shurin, Michael R.; Kagan, Valerian E.; Shvedova, Anna A.;
    Published:
    July 24 2017
    Source:
    ACS Nano. 11(8):7565-7571
    Description:
    According to the Centers for Disease Control and Prevention, approximately 25 million Americans suffer from asthma. The disease total annual cost is about $56 billion and includes both the direct and indirect costs of medications, hospital stays, mis...
    File Type:
    Filetype[PDF - 507.26 KB]
  2. Mice completely lacking immunoproteasomes display major alterations in antigen presentation
    Personal Author:
    Kincaid, Eleanor Z; Che, Jenny W; York, Ian; Escobar, Hernando; Reyes-Vargas, Eduardo; Delgado, Julio C.; Welsh, Raymond M; Karow, Margaret L.; Murphy, Andrew J.; Valenzuela, David M.; Yancopoulos, George D.; Rock, Kenneth L;
    Published:
    Dec 25 2011
    Source:
    Nat Immunol. 13(2):129-135.
    Description:
    The importance of immunoproteasomes to antigen presentation has been unclear because animals totally lacking immunoproteasomes had not been available. Having now developed mice lacking the three immunoproteasome catalytic subunits, we found that the ...
    File Type:
    Filetype[PDF - 1.69 MB]
  3. Graphene Oxide Attenuates Th2-Type Immune Responses, but Augments Airway Remodeling and Hyperresponsiveness in a Murine Model of Asthma
    Personal Author:
    Shurin, Michael R.; Yanamala, Naveena; Kisin, Elena R.; Tkach, Alexey V.; Shurin, Galina V.; Murray, Ashley R.; Leonard, Howard D.; Reynolds, Jeffrey S.; Gutkin, Dmirtiy W.; Star, Alexander; Fadeel, Bengt; Savolainen, Kai; Kagan, Valerian E.; Shvedova, Anna A.;
    Published:
    May 23 2014
    Source:
    ACS Nano. 2014; 8(6):5585-5599.
    Description:
    Several lines of evidence indicate that exposure to nanoparticles (NPs) is able to modify airway immune responses, thus facilitating the development of respiratory diseases. Graphene oxide (GO) is a promising carbonaceous nanomaterial with unique phy...
    File Type:
    Filetype[PDF - 2.49 MB]
  4. Molecular modeling in structural nano-toxicology: Interactions of nano-particles with nano-machinery of cells
    Personal Author:
    Yanamala, Naveena; Kagan, Valerian E.; Shvedova, Anna A.;
    Published:
    May 28 2013
    Source:
    Adv Drug Deliv Rev. 65(15):2070-2077.
    Description:
    Over the past two decades, nanotechnology has emerged as a key player in various disciplines of science and technology. Some of the most exciting applications are in the field of biomedicine - for theranostics (for combined diagnostic and therapeutic...
    File Type:
    Filetype[PDF - 1.37 MB]
  5. Applications of Nanotechnology in Dermatology
    Personal Author:
    DeLouise, Lisa A.
    Published:
    Jan 05 2012
    Source:
    J Invest Dermatol. 132(3 0 2):964-975.
    Description:
    What are nanoparticles and why are they important in dermatology? These questions are addressed by highlighting recent developments in the nanotechnology field that have increased the potential for intentional and unintentional nanoparticle skin expo...
    File Type:
    Filetype[PDF - 2.00 MB]